I use https://pubmed.ncbi.nlm.nih.gov/35219763.


Drs. Doxey , Eberini , Jungo , Kough , Palazzolo , Pereira Mouriès and Rodriguez have no conflict of interests to declare .
Drs. Doxey have no conflict of interests to declare .
Drs. Eberini have no conflict of interests to declare .
Drs. Jungo have no conflict of interests to declare .
Drs. Kough have no conflict of interests to declare .
Drs. Palazzolo have no conflict of interests to declare .
Drs. Pereira Mouriès have no conflict of interests to declare .
Drs. Rodriguez have no conflict of interests to declare .

Dr. Krishan was Im- mediate Past President of the SOT Food Safety Specialty Section (2020–2021) at the time of this workshop and represented the SOT Food Safety Specialty Section during the event .
Dr. Krishan was Im- mediate Past President of the SOT Food Safety Specialty Section (2020–2021) at the time of this workshop .
Dr. Krishan represented the SOT Food Safety Specialty Section during the event .

Dr. Satchell has significant financial interests in Situ Biosciences, a contract research organization that conducts research unrelated to this work .


She holds patents on use of bacterial toxins as therapeutics .


Dr. Bauman is an employee of Syngenta Crop Protection LLC, a crop protection company .


Dr. Islamoviv and Dr. Privalle are employees of BAndre SilvanovichF, a crop protection and chemical company .
Dr. Islamoviv are employees of BAndre SilvanovichF, a crop protection company .
Dr. Islamoviv are employees of BAndre SilvanovichF, a chemical company .
Dr. Privalle are employees of BAndre SilvanovichF, a crop protection company .
Dr. Privalle are employees of BAndre SilvanovichF, a chemical company .

Mr. Kessenich and Dr. Silvanovich are employees of Bayer CropScience, a crop protection company .
Mr. Kessenich are employees of Bayer CropScience, a crop protection company .
Dr. Silvanovich are employees of Bayer CropScience, a crop protection company .

They have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. 4 Round table discussion: key opportunities, challenges, and proposed solutions to improving the assessment of protein toxicity 5 Key learnings and needs identified Disclaimer Funding COI statement Acknowledgements Appendix A Supplementary data References.
They have no known competing financial interests that could have appeared to influence the work reported in this paper. 4 Round table discussion: key opportunities, challenges, statement Acknowledgements Appendix A Supplementary data References.
They have no known competing personal relationships that could have appeared to influence the work reported in this paper. 4 Round table discussion: key opportunities, challenges, statement Acknowledgements Appendix A Supplementary data References.
They have no known competing financial interests that could have appeared to influence the work reported in this paper. 4 Round table discussion: proposed solutions to improving the assessment of protein toxicity 5 Key learnings identified Disclaimer Funding COI statement Acknowledgements Appendix A Supplementary data References.
They have no known competing financial interests that could have appeared to influence the work reported in this paper. 4 Round table discussion: proposed solutions to improving the assessment of protein toxicity 5 Key needs identified Disclaimer Funding COI statement Acknowledgements Appendix A Supplementary data References.
They have no known competing personal relationships that could have appeared to influence the work reported in this paper. 4 Round table discussion: proposed solutions to improving the assessment of protein toxicity 5 Key learnings identified Disclaimer Funding COI statement Acknowledgements Appendix A Supplementary data References.
They have no known competing personal relationships that could have appeared to influence the work reported in this paper. 4 Round table discussion: proposed solutions to improving the assessment of protein toxicity 5 Key needs identified Disclaimer Funding COI statement Acknowledgements Appendix A Supplementary data References.

Funding This activity was supported by the Protein Allergens , Toxins and Bioinformatics (PATB) technical committee of the Health and Environ- mental Sciences Institute (HESI) .
Funding This activity was supported by the Protein Allergens (PATB) technical committee of the Health mental Sciences Institute (HESI) .
Funding This activity was supported by the Protein Allergens (PATB) technical committee of the Environ- mental Sciences Institute (HESI) .
Funding This activity was supported by the Protein Toxins (PATB) technical committee of the Health mental Sciences Institute (HESI) .
Funding This activity was supported by the Protein Toxins (PATB) technical committee of the Environ- mental Sciences Institute (HESI) .
Funding This activity was supported by the Protein Bioinformatics (PATB) technical committee of the Health mental Sciences Institute (HESI) .
Funding This activity was supported by the Protein Bioinformatics (PATB) technical committee of the Environ- mental Sciences Institute (HESI) .

The Food Safety Specialty Section (FS3) of the Society of Toxicology (SOT) collaborated with HESI PATB, helped plan the workshop, provided scientific inputs, speaker recom- mendations, and disseminated the workshop announcement to SOT FS3 membership .
The Food Safety Specialty Section (FS3) of the Society of Toxicology (SOT) collaborated with HESI PATB, helped plan the workshop, provided scientific inputs, speaker recom- mendations, .
The Food Safety Specialty Section (FS3) of the Society of Toxicology (SOT) disseminated the workshop announcement to SOT FS3 membership .

SOT FS3 did not provide any funding support for this workshop .


This activity was supported by the Protein Allergens , Toxins and Bioinformatics (PATB) technical committee of the Health and Environ- mental Sciences Institute (HESI) .
This activity was supported by the Protein Allergens (PATB) technical committee of the Health mental Sciences Institute (HESI) .
This activity was supported by the Protein Allergens (PATB) technical committee of the Environ- mental Sciences Institute (HESI) .
This activity was supported by the Toxins (PATB) technical committee of the Health mental Sciences Institute (HESI) .
This activity was supported by the Toxins (PATB) technical committee of the Environ- mental Sciences Institute (HESI) .
This activity was supported by the Bioinformatics (PATB) technical committee of the Health mental Sciences Institute (HESI) .
This activity was supported by the Bioinformatics (PATB) technical committee of the Environ- mental Sciences Institute (HESI) .

The Food Safety Specialty Section (FS3) of the Society of Toxicology (SOT) collaborated with HESI PATB, helped plan the workshop, provided scientific inputs, speaker recom- mendations, and disseminated the workshop announcement to SOT FS3 membership .
The Food Safety Specialty Section (FS3) of the Society of Toxicology (SOT) collaborated with HESI PATB, helped plan the workshop, provided scientific inputs, speaker recom- mendations, .
The Food Safety Specialty Section (FS3) of the Society of Toxicology (SOT) disseminated the workshop announcement to SOT FS3 membership .

SOT FS3 did not provide any funding support for this workshop .


COI statement 4 Round table discussion: key opportunities, challenges, and proposed solutions to improving the assessment of protein toxicity 5 Key learnings and needs identified Disclaimer Funding COI statement Acknowledgements Appendix A Supplementary data References.
COI statement 4 Round table discussion: key opportunities, challenges, 5 Key learnings identified Disclaimer Funding COI statement Acknowledgements Appendix A Supplementary data References.
COI statement 4 Round table discussion: key opportunities, challenges, 5 Key needs identified Disclaimer Funding COI statement Acknowledgements Appendix A Supplementary data References.
COI statement 4 Round table discussion: proposed solutions to improving the assessment of protein toxicity 5 Key learnings identified Disclaimer Funding COI statement Acknowledgements Appendix A Supplementary data References.
COI statement 4 Round table discussion: proposed solutions to improving the assessment of protein toxicity 5 Key needs identified Disclaimer Funding COI statement Acknowledgements Appendix A Supplementary data References.

Acknowledgements The authors gratefully acknowledge the contributions of all speakers, the input from workshop participants of all sectors and geographical areas for enriching the discussions, as well as the SOT F3S for their partnership in organizing this meeting .
Acknowledgements The authors gratefully acknowledge the contributions of all speakers, the input from workshop participants of all sectors for enriching the discussions, as well as the SOT F3S for their partnership in organizing this meeting .
Acknowledgements The authors gratefully acknowledge the contributions of all speakers, the input from workshop participants of all geographical areas for enriching the discussions, as well as the SOT F3S for their partnership in organizing this meeting .

The authors also thank former HESI staff , Ms. Carolina Morell-Perez, for her support at various stages of the workshop planning. 4 Round table discussion: key opportunities, challenges, and proposed solutions to improving the assessment of protein toxicity 5 Key learnings and needs identified Disclaimer Funding COI statement Acknowledgements Appendix A Supplementary data References.
The authors also thank former HESI staff , Ms. Carolina Morell-Perez, for her support at various stages of the workshop planning. 4 Round table discussion: key opportunities, challenges, Disclaimer Funding COI statement Acknowledgements Appendix A Supplementary data References.
The authors also thank former HESI staff , Ms. Carolina Morell-Perez, for her support at various stages of the workshop planning. 4 Round table discussion: proposed solutions to improving the assessment of protein toxicity 5 Key learnings identified Disclaimer Funding COI statement Acknowledgements Appendix A Supplementary data References.
The authors also thank former HESI staff , Ms. Carolina Morell-Perez, for her support at various stages of the workshop planning. 4 Round table discussion: proposed solutions to improving the assessment of protein toxicity 5 Key needs identified Disclaimer Funding COI statement Acknowledgements Appendix A Supplementary data References.

I use https://pubmed.ncbi.nlm.nih.gov/32197968.


They have no known competing financial interests or personal relationships that could have appeared to influ- ence the work reported in this paper .


Concluding remarks Funding References.


Funding The authors state that the funding agencies (National Institutes of Health [U54AT008909 and R01GM121354] and ''Carly's Law'' (State of Alabama)) had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the manuscript, and in the decision to submit the article for publication .
Funding The authors state that the funding agencies (National Institutes of Health [U54AT008909 and R01GM121354] and ''Carly's Law'' (State of Alabama)) had no role in the decision to submit the article for publication .
Funding The authors state that the funding agencies (National Institutes of Health [U54AT008909 and R01GM121354] and ''Carly's Law'' (State of Alabama)) had no role in the study design; in the collection, analysis, of data; in the writing of the manuscript, .
Funding The authors state that the funding agencies (National Institutes of Health [U54AT008909 and R01GM121354] and ''Carly's Law'' (State of Alabama)) had no role in the study design; in the interpretation of data; in the writing of the manuscript, .

The authors state that the funding agencies (National Institutes of Health [U54AT008909 and R01GM121354] and ''Carly's Law'' (State of Alabama)) had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the manuscript, and in the decision to submit the article for publication .
The authors state that the funding agencies (National Institutes of Health [U54AT008909 and R01GM121354] and ''Carly's Law'' (State of Alabama)) had no role in the decision to submit the article for publication .
The authors state that the funding agencies (National Institutes of Health [U54AT008909 and R01GM121354] and ''Carly's Law'' (State of Alabama)) had no role in the study design; in the collection, analysis, of data; in the writing of the manuscript, .
The authors state that the funding agencies (National Institutes of Health [U54AT008909 and R01GM121354] and ''Carly's Law'' (State of Alabama)) had no role in the study design; in the interpretation of data; in the writing of the manuscript, .

Concluding remarks Funding References.
